GSK Secures High Blood Pressure Drug in $950 Million Deal

GSK Secures High Blood Pressure Drug in 0 Million Deal



GSK Secures High Blood Pressure Drug in $950 Million Deal
GSK Plc agreed to buy 35Pharma Inc., a biotech with an early-stage high blood pressure drug, as the UK pharmaceutical company expands into cardiovascular medicine.


www.bloomberg.com
#GSK #Secures #High #Blood #Pressure #Drug #Million #Deal

Share: X · Facebook · LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *